May 10 |
Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
|
May 9 |
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
|
May 9 |
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
|
May 9 |
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
|
May 9 |
Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
|
May 9 |
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2024 Earnings Call Transcript
|
May 8 |
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
|
May 8 |
Amphastar Pharmaceuticals Non-GAAP EPS of $1.04 beats by $0.25, revenue of $171.8M misses by $2.91M
|
May 8 |
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
|
May 7 |
Amphastar Pharmaceuticals Q1 2024 Earnings Preview
|